Glucose uptake assay

LM Liza D. Morales
DC Douglas T. Cromack
DT Devjit Tripathy
MF Marcel Fourcaudot
SK Satish Kumar
JC Joanne E. Curran
MC Melanie Carless
HG Harald H. H. Göring
SH Shirley L. Hu
JL Juan Carlos Lopez-Alvarenga
KG Kristina M. Garske
PP Päivi Pajukanta
KS Kerrin S. Small
CG Craig A. Glastonbury
SD Swapan K. Das
CL Carl Langefeld
RH Robert L. Hanson
WH Wen-Chi Hsueh
LN Luke Norton
RA Rector Arya
SM Srinivas Mummidi
JB John Blangero
RD Ralph A. DeFronzo
RD Ravindranath Duggirala
CJ Christopher P. Jenkinson
request Request a Protocol
ask Ask a question
Favorite

The glucose uptake assay (Abcam, Inc.,Cambridge, MA) was performed according to the manufacturer’s instructions. Briefly, pre-adipocytes were differentiated to adipocytes as described and maintained for an additional 4 days. Cultured cells were then starved overnight as described. Cultured cells were washed and starved in KRPH + 2% BSA buffer. Then 1 µM insulin and 2-deoxyglucose (2-DG) were added to activate glucose transporters to take up 2-DG and metabolize it to 2-DG-6-phosphate (2-DG6P). The accumulated 2-DG6P was oxidized to NADPH which generated an oxidized substrate that was measured at OD412nm using a microplate reader. A 2-DG6P standard curve was also measured at the same time. Absorbance values were normalized to the mean “blank” absorbance value. Cells not treated with insulin or 2-DG were used as sample background controls. 2-DG uptake [µM] was calculated as: (Calculated concentration of 2-DG6P/Sample volume) × Sample dilution. The experiment was performed three times, and data were presented as the mean ± s.e.m. Results were analyzed with Microsoft Excel software by applying the equal variance t Test. P ≤ 0.05 was considered statistically significant.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A